Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-05

Clinical Trial Update: Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing single-dose cefepime to cefuroxime plus metronidazole as prophylaxis during emergency intrapartum cesarean section; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefepime (cefepime)
  • METRONIDAZOLE (Metronidazole)
  • cefuroxime (cefuroxime)

Snippet

Sponsor: Assiut University | Conditions: Emergency Cesarean Section, Infection Wound | Phase 2, Phase 3 | Status: UNKNOWN